Stocks Health care STAA
NASDAQ · Health careStaar Surgical Co (STAA)
Staar Surgical Co brought in $328.3M of revenue over the twelve months to October 2, 2026, up 42.4% from a year earlier. Net income was $530K, a net margin of 0.2%. In fiscal 2025 capital spending exceeded operating cash flow by $40.1M. At October 2, 2026 it held $133.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about Staar Surgical Co
- Net worth
- Staar Surgical Co has a market value (market cap) of $1.2B at the latest share price, and shareholders' equity of $376.1M on its balance sheet at October 2, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $239.4M (-23.7% year on year), with a net loss of $80.4M. Over the 12 months to October 2, 2026: revenue $328.3M, net income $530K.
- Cash flow
- In fiscal 2025 operations used $34.2M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to October 2, 2026. Open on SEC EDGAR
- Next earnings report
- Staar Surgical Co's next report is expected around January 27, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Staar Surgical Co does
Staar Surgical Co is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NASDAQ under the ticker STAA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $239.4M | -$80.4M | -$1.62 | -$40.1M |
| 2024 | $313.9M | -$20.2M | -$0.41 | -$7.7M |
| 2023 | $322.4M | $21.3M | $0.43 | -$3.6M |
| 2022 | $239.4M | $39.7M | $0.80 | $17.6M |
| 2021 | $230.5M | $27.5M | $0.56 | $30.3M |
| 2020 | $163.5M | $5.9M | $0.13 | $12.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where STAA ranks in Health care
Latest SEC filings
What Staar Surgical Co has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Quarterly report 10-Q · period to October 2, 2026Revenue fell 12% to $83.4M versus the same quarter last year; diluted EPS $0.11 versus $0.18.
- November 4, 2026
- October 27, 2026Passive stake changed SCHEDULE 13G/A
- October 5, 2026Executive or director change8-K/ASTAAR Surgical appointed former Chief Executive Officer David Bailey as Chief Commercial Officer.
- September 10, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Quarterly report 10-Q · period to July 3, 2026Revenue rose 111% to $93.5M versus the same quarter last year; diluted EPS $0.16 versus -$0.34.
- August 12, 2026
- August 6, 2026
- June 24, 2026
Insider trades
What the people running Staar Surgical Co did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 10 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 14, 2026 | Andrews Deborah JChief Financial Officer & EVP | Exercised options | 5,233 | - |
| August 14, 2026 | Andrews Deborah JChief Financial Officer & EVP | Shares withheld for tax | 2,662 | $69.7K |
| August 14, 2026 | Michna MagdaChief Development Officer | Exercised options | 5,499 | - |
| August 14, 2026 | Michna MagdaChief Development Officer | Shares withheld for tax | 2,797 | $73.2K |
| August 14, 2026 | Michna MagdaChief Development Officer | Shares withheld for tax | 559 | $14.6K |
| August 14, 2026 | Michna MagdaChief Development Officer | Exercised options | 1,100 | $28.8K |
| August 14, 2026 | Foust WarrenPresident and CEO | Exercised options | 7,331 | - |
| August 14, 2026 | Foust WarrenPresident and CEO | Shares withheld for tax | 3,730 | $97.7K |
Who owns STAA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Neal C. Bradsher13D, may seek influence with 3 related filers | 32.6% | March 13, 2026 |
| Madison Avenue International LP13G, passive with 5 related filers | 8.4% | August 14, 2026 |
| Yunqi Capital Limited13D, may seek influence with 7 related filers | 6.5% | January 16, 2026 |
| Point72 Asset Management, L.P.13G, passive with 2 related filers | 5.2% | May 12, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 200 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Broadwood Capital Inc | 16,123,842 | 0 |
| BlackRock, Inc. | 6,731,154 | +65,036 |
| Madison Avenue Partners, LP | 4,175,748 | +1,734,070 |
| Yunqi Capital Ltd | 3,257,130 | 0 |
| Point72 Asset Management, L.P. | 2,437,446 | +1,614,294 |
| Goldman Sachs Group Inc | 2,150,809 | +1,080,870 |
| Vanguard Portfolio Management LLC | 1,979,573 | -144,016 |
| State Street Corp | 1,769,354 | -63,642 |
| Anatole Investment Management Ltd | 1,651,701 | +50,000 |
| Vanguard Capital Management LLC | 1,552,743 | -137,863 |
| Morgan Stanley | 1,316,119 | -183,237 |
| Geode Capital Management, LLC | 1,076,006 | +59,502 |
| Two Seas Capital LP | 1,064,389 | +27,416 |
| Dimensional Fund Advisors LP | 867,142 | +46,360 |
| American Capital Management Inc | 846,659 | -31,376 |
| AI-Squared Management Ltd | 542,420 | +274,336 |
| Charles Schwab Investment Management Inc | 445,713 | +37,137 |
| Defender Capital, LLC. | 431,187 | -213,355 |
| Northern Trust Corp | 423,112 | +22,894 |
| Norges Bank | 365,200 | new |
Insiders
9 insiders reported holding 32,552,500 shares in total, about $777M at the last price.
| Holder | Shares |
|---|---|
| Broadwood Partners, L.P.Director, 10% owner | 32,247,68416,123,842 held indirectly |
| Foust WarrenPresident and CEO | 95,816 |
| Jiang WeiDirector | 77,127 |
| Michna MagdaChief Development Officer | 41,343 |
| Andrews Deborah JChief Financial Officer & EVP | 38,910 |
| Sisitsky NathanielChief Legal Officer | 22,812 |
| Silverman LouDirector | 11,158 |
| Butcher Arthur CDirector | 9,549 |
| Zhou Lilian YanshengDirector | 8,101 |
Questions about STAA
What does Staar Surgical Co do?
Staar Surgical Co is a company in the Health care sector, listed on NASDAQ as STAA. Its shares trade on NASDAQ under the ticker STAA.
What is Staar Surgical Co's net worth?
Staar Surgical Co has a market value (market cap) of $1.2B at the latest share price, and shareholders' equity of $376.1M on its balance sheet at October 2, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Staar Surgical Co profitable?
Yes. Over the twelve months to October 2, 2026 it reported net income of $530K on revenue of $328.3M, a net margin of 0.2%.
How much revenue does Staar Surgical Co make?
Over the twelve months to October 2, 2026 Staar Surgical Co reported revenue of $328.3M. That is 42.4% more than a year earlier.
When did Staar Surgical Co last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to October 2, 2026.
When is Staar Surgical Co's next earnings report?
Staar Surgical Co's next report is expected around January 27, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare STAA with
Follow STAA
Get an email when Staar Surgical Co files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Staar Surgical Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.